Publisher Correction: Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance (Nature, (2023), 617, 7960, (377-385), 10.1038/s41586-023-06026-3)

Joon Seok Park; Francesca S. Gazzaniga; Meng Wu; Amalia K. Luthens; Jacob Gillis; Wen Zheng; Martin W. LaFleur; Sarah B. Johnson; Golnaz Morad; Elizabeth M. Park; Yifan Zhou; Stephanie S. Watowich; Jennifer A. Wargo; Gordon J. Freeman; Dennis L. Kasper; Arlene H. Sharpe

doi:10.1038/s41586-023-06237-8

Publisher Correction: Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance (Nature, (2023), 617, 7960, (377-385), 10.1038/s41586-023-06026-3)

Joon Seok Park
, Francesca S. Gazzaniga
, Meng Wu
, Amalia K. Luthens
, Jacob Gillis
, Wen Zheng
, Martin W. LaFleur
, Sarah B. Johnson
, Golnaz Morad
, Elizabeth M. Park
, Yifan Zhou
, Stephanie S. Watowich
, Jennifer A. Wargo
, Gordon J. Freeman
, Dennis L. Kasper
, Arlene H. Sharpe

Research output: Contribution to journal › Comment/debate

4 Scopus citations

Abstract

Correction to: Nature Published online 3 May 2023 In the version of the article originally published, in Figure 4a, the left- and right-hand labels now reading “Anti-PD-L2” originally read “Anti-PD-L1”. The labels have been corrected in the HTML and PDF versions of the article.

Original language	English
Pages (from-to)	E27
Journal	Nature
Volume	618
Issue number	7966
DOIs	https://doi.org/10.1038/s41586-023-06237-8
State	Published - Jun 22 2023

Access to Document

10.1038/s41586-023-06237-8

Cite this

Park, J. S., Gazzaniga, F. S., Wu, M., Luthens, A. K., Gillis, J., Zheng, W., LaFleur, M. W., Johnson, S. B., Morad, G., Park, E. M., Zhou, Y., Watowich, S. S., Wargo, J. A., Freeman, G. J., Kasper, D. L., & Sharpe, A. H. (2023). Publisher Correction: Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance (Nature, (2023), 617, 7960, (377-385), 10.1038/s41586-023-06026-3). Nature, 618(7966), E27. https://doi.org/10.1038/s41586-023-06237-8

@article{c35cf1c8b7254e7fa98c550ef47a3d4b,

title = "Publisher Correction: Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance (Nature, (2023), 617, 7960, (377-385), 10.1038/s41586-023-06026-3)",

abstract = "Correction to: Nature Published online 3 May 2023 In the version of the article originally published, in Figure 4a, the left- and right-hand labels now reading “Anti-PD-L2” originally read “Anti-PD-L1”. The labels have been corrected in the HTML and PDF versions of the article.",

author = "Park, \{Joon Seok\} and Gazzaniga, \{Francesca S.\} and Meng Wu and Luthens, \{Amalia K.\} and Jacob Gillis and Wen Zheng and LaFleur, \{Martin W.\} and Johnson, \{Sarah B.\} and Golnaz Morad and Park, \{Elizabeth M.\} and Yifan Zhou and Watowich, \{Stephanie S.\} and Wargo, \{Jennifer A.\} and Freeman, \{Gordon J.\} and Kasper, \{Dennis L.\} and Sharpe, \{Arlene H.\}",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s), under exclusive licence to Springer Nature Limited.",

year = "2023",

month = jun,

day = "22",

doi = "10.1038/s41586-023-06237-8",

language = "English",

volume = "618",

pages = "E27",

journal = "Nature",

issn = "0028-0836",

number = "7966",

}

Park, JS, Gazzaniga, FS, Wu, M, Luthens, AK, Gillis, J, Zheng, W, LaFleur, MW, Johnson, SB, Morad, G, Park, EM, Zhou, Y, Watowich, SS, Wargo, JA, Freeman, GJ, Kasper, DL & Sharpe, AH 2023, 'Publisher Correction: Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance (Nature, (2023), 617, 7960, (377-385), 10.1038/s41586-023-06026-3)', Nature, vol. 618, no. 7966, pp. E27. https://doi.org/10.1038/s41586-023-06237-8

TY - JOUR

T1 - Publisher Correction

T2 - Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance (Nature, (2023), 617, 7960, (377-385), 10.1038/s41586-023-06026-3)

AU - Park, Joon Seok

AU - Gazzaniga, Francesca S.

AU - Wu, Meng

AU - Luthens, Amalia K.

AU - Gillis, Jacob

AU - Zheng, Wen

AU - LaFleur, Martin W.

AU - Johnson, Sarah B.

AU - Morad, Golnaz

AU - Park, Elizabeth M.

AU - Zhou, Yifan

AU - Watowich, Stephanie S.

AU - Wargo, Jennifer A.

AU - Freeman, Gordon J.

AU - Kasper, Dennis L.

AU - Sharpe, Arlene H.

PY - 2023/6/22

Y1 - 2023/6/22

N2 - Correction to: Nature Published online 3 May 2023 In the version of the article originally published, in Figure 4a, the left- and right-hand labels now reading “Anti-PD-L2” originally read “Anti-PD-L1”. The labels have been corrected in the HTML and PDF versions of the article.

AB - Correction to: Nature Published online 3 May 2023 In the version of the article originally published, in Figure 4a, the left- and right-hand labels now reading “Anti-PD-L2” originally read “Anti-PD-L1”. The labels have been corrected in the HTML and PDF versions of the article.

UR - https://www.scopus.com/pages/publications/85160815344

U2 - 10.1038/s41586-023-06237-8

DO - 10.1038/s41586-023-06237-8

M3 - Comment/debate

C2 - 37264079

AN - SCOPUS:85160815344

SN - 0028-0836

VL - 618

SP - E27

JO - Nature

JF - Nature

IS - 7966

ER -

Publisher Correction: Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance (Nature, (2023), 617, 7960, (377-385), 10.1038/s41586-023-06026-3)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this